Stocks Hitting 52-Week Lows

Related MDCO Mid-Morning Market Update: Markets Gain; Ford March Sales Rise 3% Morning Market Losers Related NRX Stocks Hitting 52-Week Lows

The Medicines Company (NASDAQ: MDCO) shares touched a new 52-week low of $24.17 after the company provided an update on Angiomax patent litigation.

NephroGenex (NASDAQ: NRX) shares reached a new 52-week low of $6.67. On Monday, NephroGenex posted a full-year net loss of $6.3 million, or $19.71 per share.

Bio-Path Holdings (NASDAQ: BPTH) shares declined 5.66% to touch a new 52-week low of $2.50. Bio-Path shares have jumped 349.15% over the past 52 weeks, while the S&P 500 index has gained 19.24% in the same period.

Akers Biosciences (NASDAQ: AKER) shares reached a new 52-week low of $3.85. Akers Biosciences' trailing-twelve-month ROE is -41.12%.

Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets

Top 5 Oil Stocks To Buy For 2014

© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  Most Popular Plug Power - Getting Charged Up To Rally? Barron's Recap: Bad News For Putin The Future Of Marijuana Policy: Northwest Prana Biotech Announces Preliminary Reults of Phase 2 IMAGINE trial of PBT2 UPDATE: Whole Foods Acquires Four Stores From New Frontiers Bank of America Reiterates Underperform on 3D Systems and Lowered PT on Lower LT Margin Related Articles (BPTH + AKER) Stocks Hitting 52-Week Lows Stocks Hitting 52-Week Lows Around the Web, We're Loving...